Clinical experiences of summary of transurethral resection of prostate for begign prostatic hyperplasia with coronary stent

doi:10.3877/cma.j.issn.1674-3253.2017.02.006

Abstract

Abstract:

Objective

To summarize the experiences of transurethral resection of prostate(TURP) in the treatment of prostatic hyperplasia patients with coronary stent.

Methods

The clinical data of 56 BPH patients with coronary stent underwent TURP in our department between 2010 and 2015 were reviewed, aging from 57-86 years and 72 years in average. All patients were treated with TURP operation with fully perioperative preparation including assessment of the risk of surgical anesthesia, blood pressure, cardiac function improvement and suspending the anticoagulation.

Results

All of the operations were performed successfully without severe complications during the perioperative period. No cardiovascular and cerebrovascular complications and death occurred. The international prostate symptom scores (IPSS) reduced from (26±5) to (12±5), and quality of life scores (QOL) reduced from (5.1±0.8) to (1.9±1.1) postoperatively.

Conclusion

With fully preoperative preparation, TURP is safe and effective for patients with BPH and coronary sent.

Key words: BPH, coronary stent, TURP

Jiahui Zhao, Yongguang Jiang, Zhu Hou, tao Peng, Yongxing Wang, Yong Luo, Mingchuan Li. Clinical experiences of summary of transurethral resection of prostate for begign prostatic hyperplasia with coronary stent[J]. Chinese Journal of Endourology(Electronic Edition), 2017, 11(02): 101-104.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjmnmwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3253.2017.02.006

https://zhqjmnmwkzz.cma-cmc.com.cn/EN/Y2017/V11/I02/101

References 15

[1]	Gyomber D, Lawrentschuk N, Ranson DL, et al. An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy[J]. BJU Int, 2006, 97(4):758-761.
[2]	Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation[J]. J Am Coll Cardiol, 2005, 45(6):947-953.
[3]	de la Torre-Hernández JM, Alfonso F, Hernández F, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)[J]. J Am Coll Cardiol, 2008, 51(10):986-990.
[4]	Murray J, Saxena S, Millett C, et al. Reductions in risk factors for secondary prevention of coronary heart disease by ethnic group in south-west London: 10-year longitudinal study (1998-2007)[J]. Fam Pract, 2010, 27(4):430-438.
[5]	Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis[J]. J Intern Med, 2005, 257(5):399-414.
[6]	Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease[J]. Eur Heart J, 2006, 27(22):2667-2674.
[7]	Donat R, Wilson I, Raza A, et al. A multicentre prospective, randomised, doubleblind placebo-controlled trial of aspirin during transurethral resection of the prostate (TURP)[J]. J Urol, 2003, 169(2):466-467.
[8]	Taylor K, Filgate R, Guo DY, et al. A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs[J]. BJU Int, 2011, 108(2):45-50.
[9]	Wenders M, Wenzel O, Nitzke T, et al. Perioperative platelet inhibition in transurethral interventions: TURP/TURB[J]. Int Braz J Urol, 2012, 38(5):606-610.
[10]	Nielsen JD, Holm-Nielsen A, Jespersen J, et al. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study[J]. Scand J Urol Nephrol, 2000, 34(3):194-198.
[11]	Enver MK, Hoh I, Chinegwundoh FI. The management of aspirin in transurethral prostatectomy: current practice in the UK[J]. Ann R Coll Surg Engl, 2006, 88(3):280-283.
[12]	杨毅，陈荣，吴德锋,等.经尿道前列腺电切术术前停服阿司匹林的时机选择[J].浙江实用医学, 2015, 20(3):201-203.
[13]	袁渊，姚启盛，王晓康,等.高龄前列腺增生患者合并心血管疾病的围手术期处理[J].中华腔镜泌尿外科杂志:电子版, 2013, 7(1):25-28.
[14]	Rubino AS, Della Corte A, Giordano R, et al. Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting[J]. Eur J Cardiothorac Surg, 2014, 46(2):335.
[15]	Ong WL, Koh TL, Fletcher J, et al. Perioperative management of antiplatelets and anticoagulants among patients undergoing elective transurethral resection of the Prostate--A single institution experience[J]. J Endourol, 2015, 29(11):1321-1327.

Please choose a citation manager

Content to export